Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS)
FASTPASS, funded by ARPA-H, supports research to create rapid, non-destructive tools for real-time drug quality and safety screening at key points in the pharmaceutical supply chain.
Funder: Advanced Research Projects Agency for Health
Due Dates: August 20, 2026: Registration deadline for Proposer Workshop (required by 12:00 PM ET)
Funding Amounts: Funding details to be announced in the solicitation; typically ARPA-H programs support multi-million dollar, milestone-driven projects.
Summary: Supports rapid, non-destructive screening tool development to verify drug quality and safety in real time at supply chain checkpoints.
Key Information: Registration for the Proposer Workshop is required by August 20, 2026 to participate in early engagement.
Description
The Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS) program, led by the Advanced Research Projects Agency for Health (ARPA-H), aims to protect the public from substandard or contaminated medicines by enabling near real-time verification of drug quality and safety at critical points in the supply chain. The initiative focuses on the creation of rapid, non-destructive screening tools capable of assessing pharmaceuticals through packaging at ports, warehouses, and distribution centers. By integrating expertise from non-contact spectroscopy, artificial intelligence, pharmaceutical chemistry, and hardware engineering, FASTPASS seeks transformative solutions to address the urgent challenge of drug-related harm in the United States.
